Description:

The murine monoclonal antibody to globo H (clone MBr1) is raised against the breast cancer cell line MCF7 and recognizes a saccharidic epitope (CaMBr1) overexpressed on a high percentage of human breast, ovary lung and prostate carcinomas. This antigen was originally identified on the immunogen as a globo-series glycosphingolipid with a H-like determinant at its terminus (globo-H), identical to GL6 isolated from human teratocarcinoma. MAb to MBr1 was also found to be reactive with different glycoconjugates (glycoproteins, mucins and glycolipids) in breast and small cell lung carcinoma. Retrospective as well as prospective studies suggest that CaMBr1 expression is associated with tumor aggressiveness and survival outcome in breast and small cell lung cancer and that poor prognosis is more frequently associated with CaMBr1 expression on glycoproteins. The epitope recognized by the MAb to MBr1 consists of the tetrasaccharide Fucα1-2Galβ1-3GalNacβ1-3Gal, available as a synthetic oligosaccharide exploitable for the development of new anti-cancer vaccines. Carbohydrate antigens expressed at the cell surface of human cancer cells hold promise as targets for active immunization with vaccines.CaMBR1 is also expressed on some normal tissues, and its expression restricted tissue distribution makes it a suitable target for oncologic clinical applications. In particular the MAb to MBr1 can be succesfully used for immunocytochemical detection of micrometastatic cells.

Product Specification:

Clone:	MBr1
Host:	Mouse
Isotype:	IgM
Immunogen:	Membrane preparation from the human breast carcinoma cell line MCF7.
Species reactivity:	Human, Rat Cat, Dog
Specificity:	Recognizes membrane bound glycoconjugates (glycoproteins, mucins and glycolipids) expressing the globo H or its tetrasaccharide terminus. Recognizes an epitope consisting of the tetrasaccharide Fucα1-2Galβ1-3GalNacβ1-3Gal.
Crossreactivity:	Does not cross-react with mouse. Cross-reactivity with other species has not been tested.
Applications:	Flow Cytometry, ICC, IHC (FS), IHC (PS), WB
Recommended Dilutions/Conditions:	Flow Cytometry (1-10µg/ml) Immunocytochemistry (1-10µg/ml) Immunohistochemsitry (frozen sections, 1-10µg/ml) Immunohistochemistry (paraffin sections, 1-10µg/ml, no need of antigen retrieval) Western Blot (1-10µg/ml, for glycoproteins) Suggested dilutions/conditions may not be available for all applications. Optimal conditions must be determined individually for each application.
Application Notes:	Not recommended for immunoprecipitation.
Purity Detail:	Purified from concentrated hybridoma cell culture supernatant by thiophilic adsorption chromatography.
Formulation:	Liquid. In 50mM PBS, pH 8.0, containing 150mM sodium chloride. Contains no sodium azide.
Handling:	Avoid freeze/thaw cycles.
Shipping:	Shipped on Blue Ice
Long Term Storage:	+4°C

Product categoriesPharmaceuticals And Biochemic CAS 6090-98-8 conduritol F CAS 20544-37-0 2,4,8,10-Tetraoxa-3, CAS 135564-23-7 Benzaldehyde, 4-amin CAS 34169-62-5 2-Naphthalenesulfoni CAS 6305-52-8 2-Butyldecahydronaph CAS 10074-13-2 1,3-Benzenedimethane CAS 84434-05-9 Acetic acid,2-[(9-ox CAS 104748-51-8 Avilamycin K CAS 5539-08-2 Ergoline-8-carboxyli CAS 1242-56-4 Androst-1-en-3-one,1 CAS 52978-30-0 (1R,2R,3E,5E,15E,17E CAS 24471-48-5 2-Pyrenemethanol CAS 39325-01-4 Picibanil CAS 244290-68-4 Quinolinium, 7-[(die CAS 80584-90-3 1H-Benzotriazole-1-m CAS 65193-87-5 Butanoic acid, 3-oxo CAS 3563-92-6 Zylofuramine CAS 24979-74-6 Phenol,4-ethenyl-, p CAS 1067-48-7 1-Pentanamine, 5-(tr CAS 62886-59-3 Sephadex-CM C-25,ion View all products Company Profile Name:Enzo Life SciencesCategory:Corporation/Limited Liability CompanyTrade Category: ManufacturerRegistered Time: 1996Registered Capital: Above US$100 MillionLegal Representative:Employees:Address: TaksimWebsite: http://www.enzolifesciences.comProduct/Service: chemicals Our breadth of scientific expertise coupled with unique technology platforms give us the flexibility to drive innovation throughout the entire research continuum. From life sciences research discovery efforts, through drug development, and into clinical research, our comprehensive range of products are designed to support your goals. When a standard catalog product does not meet your needs, talk to us about custom solutions; we can help